Market revenue in 2023 | USD 20.6 million |
Market revenue in 2030 | USD 36.7 million |
Growth rate | 8.6% (CAGR from 2023 to 2030) |
Largest segment | Project and data management |
Fastest growing segment | Clinical Trial Design and Consultation Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Clinical Trial Design and Consultation Services, Reading and Analytical Services, Operational Imaging Services, System and Technology Support Services, Project and Data Management |
Key market players worldwide | Ixico, Navitas Organics, Medpace Holdings Inc, Clario, BioTelemetry, ProScan Imaging, Cardiovascular Imaging Technologies, Intrinsic Imaging, Resonance Health |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial imaging market will help companies and investors design strategic landscapes.
Project and data management was the largest segment with a revenue share of 28.64% in 2023. Horizon Databook has segmented the South Korea clinical trial imaging market based on clinical trial design and consultation services, reading and analytical services, operational imaging services, system and technology support services, project and data management covering the revenue growth of each sub-segment from 2018 to 2030.
Clinical trial imaging market in South Korea is expected to exhibit gradual growth during the forecast period. South Korea has become one of the top Asian countries for conducting clinical trials owing to the presence of quality clinical research infrastructure.
Moreover, the country has recently implemented various protection and safety requirements for clinical trial participants. Moreover, the government has partnered with large CROs to provide effective clinical trial services in the country.
In September 2019, South Korea launched a five-year plan for advancing clinical trials in the country. One of the major advantages that is being offered under this plan is accelerated clinical trial study with reduced review timelines of around 15 to 20 days.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea clinical trial imaging market , including forecasts for subscribers. This country databook contains high-level insights into South Korea clinical trial imaging market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account